Quartz trial
•
Non-inferiority Phase 3 RCT
NSCLC brain mets
Primary outcome QUALYs (survival and EQ-5D)
Non-inferior if no less than 7 QUALY days
BSC + steroids vs BSC + steroids + RT (20Gy/5#)
538 pts 72 centres